Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Ticagrelor versus Clopidogrel in the Dual Antiplatelet Regimen for Intracranial Stenting or Flow-Diverter Treatment for Unruptured Cerebral Aneurysms: A Single-Center Cohort Study

Ticagrelor versus Clopidogrel in the Dual Antiplatelet Regimen for Intracranial Stenting or... ORIGINAL RESEARCH INTERVENTIONAL Ticagrelor versus Clopidogrel in the Dual Antiplatelet Regimen for Intracranial Stenting or Flow-Diverter Treatment for Unruptured Cerebral Aneurysms: A Single-Center Cohort Study K.Y. Park, T. Ozaki, A. Kostynskyy, H. Kortman, A. Hilario, P. Nicholson, R. Agid, T. Krings, and V.M. Pereira ABSTRACT BACKGROUND AND PURPOSE: Ticagrelor is a novel P2Y12 antagonist, and little is known about its efficacy and safety in the endo- vascular treatment of aneurysms. This study evaluated the efficacy and safety of ticagrelor versus clopidogrel for stent-assisted coiling or flow-diversion treatment in patients with unruptured cerebral aneurysms. MATERIALS AND METHODS: From November 2003 to February 2019, two hundred one patients (mean age, 57.5 years; 156 women) with 233 unruptured aneurysms underwent stent-assisted coiling or flow-diversion treatment. All patients received antiplatelet ther- apy of aspirin plus clopidogrel (clopidogrel group, 121 patients with 140 aneurysms) or aspirin plus ticagrelor (ticagrelor group, 80 patients with 93 aneurysms). The clinical and radiologic data in each group were retrospectively reviewed and compared. RESULTS: Two hundred thirty-six procedures were performed, including stent-assisted coiling (n¼ 101) and flow diversion (n¼ 135). At 90 days, the primary outcome—a composite of any stroke and death—occurred in 9.9% of the clopidogrel group and http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Neuroradiology American Journal of Neuroradiology

Ticagrelor versus Clopidogrel in the Dual Antiplatelet Regimen for Intracranial Stenting or Flow-Diverter Treatment for Unruptured Cerebral Aneurysms: A Single-Center Cohort Study

Download PDF
7 pages
Read Article

Loading next page...
 
/lp/american-journal-of-neuroradiology/ticagrelor-versus-clopidogrel-in-the-dual-antiplatelet-regimen-for-UO7EeC6Uqu
Publisher
American Journal of Neuroradiology
Copyright
© 2021 by American Journal of Neuroradiology
ISSN
0195-6108
eISSN
1936-959X
DOI
10.3174/ajnr.A7216
Publisher site
See Article on Publisher Site

Abstract

ORIGINAL RESEARCH INTERVENTIONAL Ticagrelor versus Clopidogrel in the Dual Antiplatelet Regimen for Intracranial Stenting or Flow-Diverter Treatment for Unruptured Cerebral Aneurysms: A Single-Center Cohort Study K.Y. Park, T. Ozaki, A. Kostynskyy, H. Kortman, A. Hilario, P. Nicholson, R. Agid, T. Krings, and V.M. Pereira ABSTRACT BACKGROUND AND PURPOSE: Ticagrelor is a novel P2Y12 antagonist, and little is known about its efficacy and safety in the endo- vascular treatment of aneurysms. This study evaluated the efficacy and safety of ticagrelor versus clopidogrel for stent-assisted coiling or flow-diversion treatment in patients with unruptured cerebral aneurysms. MATERIALS AND METHODS: From November 2003 to February 2019, two hundred one patients (mean age, 57.5 years; 156 women) with 233 unruptured aneurysms underwent stent-assisted coiling or flow-diversion treatment. All patients received antiplatelet ther- apy of aspirin plus clopidogrel (clopidogrel group, 121 patients with 140 aneurysms) or aspirin plus ticagrelor (ticagrelor group, 80 patients with 93 aneurysms). The clinical and radiologic data in each group were retrospectively reviewed and compared. RESULTS: Two hundred thirty-six procedures were performed, including stent-assisted coiling (n¼ 101) and flow diversion (n¼ 135). At 90 days, the primary outcome—a composite of any stroke and death—occurred in 9.9% of the clopidogrel group and

Journal

American Journal of Neuroradiology – American Journal of Neuroradiology

Published: Sep 1, 2021

References

  • Treatment of ruptured and unruptured cerebral aneurysms in the USA: a paradigm shift
    N. Lin, KS. Cahill, KU. Frerichs
  • Treatment and diagnosis of cerebral aneurysms in the post-International Subarachnoid Aneurysm Trial (ISAT) era: trends and outcomes
    E. Luther, DJ. McCarthy, MC. Brunet
  • Heterogeneous practice patterns regarding antiplatelet medications for neuroendovascular stenting in the USA: a multicenter survey
    RW. Faught, SR. Satti, RW. Hurst
  • Assessment of dual-antiplatelet regimen for Pipeline embolization device placement: a survey of major academic neurovascular centers in the United States
    R. Gupta, JM. Moore, CJ. Griessenauer
  • Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity
    PA. Gurbel, KP. Bliden, BL. Hiatt
  • Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology
    W. Kuliczkowski, A. Witkowski, L. Polonski
  • Clopidogrel resistance is associated with thromboembolic complications in patients undergoing neurovascular stenting
    JT. Fifi, C. Brockington, J. Narang
  • Insufficient platelet inhibition and thromboembolic complications in patients with intracranial aneurysms after stent placement
    H. Yang, Y. Li, Y. Jiang
  • Relationship between low response to clopidogrel and periprocedural ischemic events with coil embolization for intracranial aneurysms
    T. Asai, S. Miyachi, T. Izumi
  • Prasugrel versus clopidogrel in stent-assisted coil embolization of unruptured intracranial aneurysms
    J. Sedat, Y. Chau, J. Gaudart
  • Low-dose prasugrel vs clopidogrel-based tailored premedication for endovascular treatment of cerebral aneurysms
    WS. Cho, J. Lee, EJ. Ha
  • Ticagrelor versus clopidogrel in patients with acute coronary syndromes.
    L. Wallentin, RC. Becker, A. Budaj
  • Long-term use of ticagrelor in patients with prior myocardial infarction
    MP. Bonaca, DL. Bhatt, M. Cohen
  • Ticagrelor versus aspirin in acute stroke or transient ischemic attack
    SC. Johnston, P. Amarenco, GW. Albers
  • Risk for major bleeding in patients receiving ticagrelor compared with aspirin after transient ischemic attack or acute ischemic stroke in the SOCRATES study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes)
  • Ticagrelor in acute stroke or transient ischemic attack in Asian patients: from the SOCRATES Trial (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes)
    Y. Wang, K. Minematsu, KS. Wong
  • Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial
    P. Amarenco, GW. Albers, H. Denison
  • First clinical experience with the new Surpass Evolve flow diverter: technical and clinical considerations
    E. Orru, H. Rice, L. De Villiers
  • Characterization of aneurysm remnants after endovascular treatment: contrast-enhanced MR angiography versus catheter digital subtraction angiography
    R. Agid, RA. Willinsky, SK. Lee
  • CE-MRA for Follow-up of Aneurysms Post Stent-Assisted Coiling
    R. Agid, M. Schaaf, R. Farb
  • Endovascular Treatment of Unruptured Aneurysms
    D. Roy, G. Milot, J. Raymond
  • Platelet testing in flow diversion: a review of the evidence
    LI. Taylor, JC. Dickerson, RJ. Dambrino
  • Management of antiplatelet therapy in patients undergoing neuroendovascular procedures
    KS. Kim, JF. Fraser, S. Grupke
  • P2Y12 reaction units threshold for implementing modified antiplatelet preparation in coil embolization of unruptured aneurysms: a prospective validation study
    CH. Kim, G. Hwang, OK. Kwon
  • Last-recorded P2Y12 reaction units value is strongly associated with thromboembolic and hemorrhagic complications occurring up to 6 months after treatment in patients with cerebral aneurysms treated with the Pipeline Embolization Device
    JE. Delgado Almandoz, BM. Crandall, JM. Scholz
  • Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention: The GRAVITAS Randomized Trial
    MJ. Price, PB. Berger, PS. Teirstein
  • Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study
    PA. Gurbel, KP. Bliden, K. Butler
  • Study of two dose regimens of ticagrelor compared with clopidogrel in patients undergoing percutaneous coronary intervention for stable coronary artery disease (STEEL-PCI)
    RC. Orme, WA. Parker, MR. Thomas
  • Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study
    PA. Gurbel, KP. Bliden, K. Butler
  • Safety and efficacy of ticagrelor for neuroendovascular procedures: a single center initial experience
    RA. Hanel, P. Taussky, T. Dixon
  • A multicenter cohort comparison study of the safety, efficacy, and cost of ticagrelor compared to clopidogrel in aneurysm flow diverter procedures
    JM. Moore, N. Adeeb, H. Shallwani
  • Comparison of two preventive dual antiplatelet regimens for unruptured intracranial aneurysm embolization with flow diverter/disrupter: a matched-cohort study comparing clopidogrel with ticagrelor
    S. Soize, C. Foussier, PF. Manceau
  • Dual antiplatelet therapy combining aspirin and ticagrelor for intracranial stenting procedures: a retrospective single center study of 154 consecutive patients with unruptured aneurysms
    AP. Narata, A. Amelot, R. Bibi
  • Heart disease and stroke statistics-2017 update: a report from the American Heart Association
  • Periprocedural complications of second-generation flow diverter treatment using Pipeline Flex for unruptured intracranial aneurysms: a systematic review and meta-analysis
    KD. Bhatia, H. Kortman, E. Orru
  • Meta-analysis of stent-assisted coiling versus coiling-only for the treatment of intracranial aneurysms
    K. Phan, YR. Huo, F. Jia
  • Endovascular treatment of intracranial aneurysms with flow diverters: a meta-analysis
    W. Brinjikji, MH. Murad, G. Lanzino
  • Outcome of intracranial flow diversion according to the antiplatelet regimen used: a systematic review and meta-analysis
    A. Podlasek, AA. Al Sultan, Z. Assis
  • WEB embolization versus stent-assisted coiling: comparison of complication rates and angiographic outcomes
    C. Kabbasch, L. Goertz, E. Siebert
  • Effect of antiplatelet therapy and platelet function testing on hemorrhagic and thrombotic complications in patients with cerebral aneurysms treated with the Pipeline Embolization Device: a review and meta-analysis
    SL. Skukalek, AM. Winkler, J. Kang